Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231

1.

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.

Su TH, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen CL, Chen PJ, Kao JH, Chen DS.

PLoS One. 2013;8(2):e55916. doi: 10.1371/journal.pone.0055916. Epub 2013 Feb 20.

PMID:
23437072
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.

Park H, Lee JM, Seo JH, Kim HS, Ahn SH, Kim do Y, Han KH, Chon CY, Park JY.

Liver Int. 2012 May;32(5):796-802. doi: 10.1111/j.1478-3231.2011.02693.x. Epub 2011 Nov 30.

PMID:
22128792
[PubMed - indexed for MEDLINE]
3.

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.

Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL.

Antivir Ther. 2012;17(1):9-17. doi: 10.3851/IMP1887.

PMID:
22267464
[PubMed - indexed for MEDLINE]
4.

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Hepatology. 2013 Feb;57(2):441-50. doi: 10.1002/hep.26041. Epub 2012 Dec 6.

PMID:
22941922
[PubMed - indexed for MEDLINE]
5.

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2011 Aug;141(2):517-25, 525.e1-2. doi: 10.1053/j.gastro.2011.04.046. Epub 2011 Apr 28.

PMID:
21672542
[PubMed - indexed for MEDLINE]
6.

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Hepatology. 2012 Jan;55(1):68-76. doi: 10.1002/hep.24615.

PMID:
21858846
[PubMed - indexed for MEDLINE]
7.

Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.

Chen J, Wang Z, Zhou B, Wang Y, Hou J.

Antivir Ther. 2012;17(1):71-9. doi: 10.3851/IMP1925.

PMID:
22267471
[PubMed - indexed for MEDLINE]
8.

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy.

Seto WK, Wong DK, Fung J, Huang FY, Lai CL, Yuen MF.

Hepatology. 2013 Sep;58(3):923-31. doi: 10.1002/hep.26376. Epub 2013 Jul 24.

PMID:
23468172
[PubMed - indexed for MEDLINE]
9.

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B, Romagnoli V, Cherubini B, Moscato G, Maina AM, Cavallone D, Bonino F.

Gastroenterology. 2010 Aug;139(2):483-90. doi: 10.1053/j.gastro.2010.04.052. Epub 2010 May 5.

PMID:
20451520
[PubMed - indexed for MEDLINE]
10.

[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].

Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish.

PMID:
17427556
[PubMed - indexed for MEDLINE]
11.

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.

Tseng TC, Kao JH.

J Gastroenterol. 2013 Jan;48(1):13-21. doi: 10.1007/s00535-012-0668-y. Epub 2012 Oct 24. Review.

PMID:
23090000
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.

J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.

PMID:
24004660
[PubMed - indexed for MEDLINE]
13.

Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.

Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S.

J Gastroenterol. 2012 Sep;47(9):1006-13. doi: 10.1007/s00535-012-0559-2. Epub 2012 Feb 29.

PMID:
22370816
[PubMed - indexed for MEDLINE]
14.

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.

Kwak MS, Cho EJ, Jang ES, Lee JH, Yu SJ, Kim YJ, Yoon JH, Lee HS.

Digestion. 2011;84 Suppl 1:23-8. doi: 10.1159/000333211. Epub 2011 Dec 2.

PMID:
22156482
[PubMed - indexed for MEDLINE]
15.

Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.

Lin LY, Wong VW, Zhou HJ, Chan HY, Gui HL, Guo SM, Wang H, Huang L, Bao SS, Xie Q, Chan HL.

J Med Virol. 2010 Sep;82(9):1494-500. doi: 10.1002/jmv.21863.

PMID:
20648602
[PubMed - indexed for MEDLINE]
16.

Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.

Fung J, Lai CL, Young J, Wong DK, Yuen J, Seto WK, Yuen MF.

Am J Gastroenterol. 2011 Oct;106(10):1766-73. doi: 10.1038/ajg.2011.253. Epub 2011 Aug 9.

PMID:
21826112
[PubMed - indexed for MEDLINE]
17.

Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.

Lee MH, Lee da M, Kim SS, Cheong JY, Cho SW.

J Med Virol. 2011 Jul;83(7):1178-86. doi: 10.1002/jmv.22089.

PMID:
21567421
[PubMed - indexed for MEDLINE]
18.

Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients.

Chan HL, Wong GL, Chim AM, Chan HY, Chu SH, Wong VW.

Antivir Ther. 2011;16(8):1249-57. doi: 10.3851/IMP1921.

PMID:
22155906
[PubMed - indexed for MEDLINE]
19.

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.

Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA.

J Hepatol. 2010 Apr;52(4):508-13. doi: 10.1016/j.jhep.2010.01.007. Epub 2010 Feb 16.

PMID:
20206400
[PubMed - indexed for MEDLINE]
20.

Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.

Kobayashi M, Akuta N, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Hosaka T, Saitoh S, Kobayashi M, Someya T, Sato J, Watabiki S, Miyakawa Y, Kumada H.

J Med Virol. 2006 Jan;78(1):60-7.

PMID:
16299721
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk